Total Payments
$45,780
2024 Payments
$598.57
Companies
11
Transactions
55
Medicare Patients
1,665
Medicare Billing
$193,691
Payment Breakdown by Category
Other$22,800 (49.8%)
Consulting$8,939 (19.5%)
Research$7,600 (16.6%)
Travel$4,830 (10.5%)
Food & Beverage$1,611 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $22,800 | 8 | 49.8% |
| Consulting Fee | $8,939 | 11 | 19.5% |
| Unspecified | $7,600 | 2 | 16.6% |
| Travel and Lodging | $4,830 | 8 | 10.5% |
| Food and Beverage | $1,611 | 26 | 3.5% |
Payments by Type
General
$38,180
53 transactions
Research
$7,600
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24,097 | 24 | $0 (2019) |
| ABBVIE INC. | $11,031 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,578 | 3 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $3,791 | 3 | $0 (2017) |
| ZIMVIE INC. | $811.67 | 3 | $0 (2024) |
| Endogastric Solutions, Inc | $136.31 | 1 | $0 (2024) |
| PFIZER INC. | $115.40 | 2 | $0 (2024) |
| GENZYME CORPORATION | $84.70 | 1 | $0 (2022) |
| KVK-Tech, Inc. | $55.45 | 9 | $0 (2022) |
| Boston Scientific Corporation | $50.38 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $598.57 | 4 | ZIMVIE INC. ($376.95) |
| 2023 | $3,893 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($1,978) |
| 2022 | $2,068 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($1,920) |
| 2021 | $3,608 | 6 | AbbVie Inc. ($1,900) |
| 2020 | $7,619 | 5 | AbbVie Inc. ($7,600) |
| 2019 | $8,886 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($8,886) |
| 2018 | $15,211 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15,211) |
| 2017 | $3,897 | 5 | Valeant Pharmaceuticals North America LLC ($3,791) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ZIMVIE INC. | TAPERED SCREW-VENT (Device) | Travel and Lodging | In-kind items and services | $376.95 | General |
| Category: Dental | ||||||
| 07/18/2024 | Boston Scientific Corporation | Resolution 360 ULTRA Clip (Device) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Resolution 360_ENDO | ||||||
| 05/21/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $59.40 | General |
| 04/29/2024 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $136.31 | General |
| Category: GERD | ||||||
| 11/28/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $56.00 | General |
| 10/26/2023 | ZIMVIE INC. | TAPERED SCREW-VENT (Device) | Food and Beverage | In-kind items and services | $101.37 | General |
| Category: Dental | ||||||
| 10/06/2023 | ZIMVIE INC. | TAPERED SCREW-VENT (Device) | Travel and Lodging | In-kind items and services | $333.35 | General |
| Category: Dental | ||||||
| 09/07/2023 | ABBVIE INC. | CREON (Drug) | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Consulting Fee | Cash or cash equivalent | $1,977.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $84.70 | General |
| Category: Immunology | ||||||
| 07/12/2022 | Boston Scientific Corporation | General - Polypectomy (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: General - Polypectomy_ENDO | ||||||
| 05/02/2022 | Medtronic, Inc. | PILLCAM (Device) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Capsule Endoscopy | ||||||
| 04/19/2022 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $5.20 | General |
| 04/13/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Consulting Fee | Cash or cash equivalent | $1,920.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/06/2022 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $3.74 | General |
| 10/14/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $4.95 | General |
| 08/13/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $13.52 | General |
| 08/09/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2.26 | General |
| 01/21/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $7.18 | General |
| 01/15/2021 | AbbVie Inc. | CREON (Drug) | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/14/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.20 | General |
| 09/14/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.20 | General |
| 09/14/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.20 | General |
| 09/08/2020 | AbbVie Inc. | CREON (Drug) | — | Cash or cash equivalent | $3,800.00 | Research |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 323 | 339 | $758,816 | $40,869 |
| 2022 | 14 | 433 | 457 | $988,984 | $54,518 |
| 2021 | 14 | 442 | 482 | $768,101 | $50,069 |
| 2020 | 16 | 467 | 512 | $717,456 | $48,235 |
Total Patients
1,665
Total Services
1,790
Medicare Billing
$193,691
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 61 | 62 | $248,230 | $14,312 | 5.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 64 | $53,642 | $7,050 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 46 | 53 | $21,349 | $4,238 | 19.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 23 | $64,725 | $3,667 | 5.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $119,090 | $3,642 | 3.1% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 13 | 13 | $59,107 | $2,295 | 3.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 36 | 41 | $9,939 | $2,030 | 20.4% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 20 | 20 | $129,240 | $1,854 | 1.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $53,494 | $1,783 | 3.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 73 | 74 | $305,464 | $15,969 | 5.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 52 | $41,872 | $6,084 | 14.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 29 | $28,706 | $4,918 | 17.1% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 24 | 24 | $110,529 | $4,232 | 3.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 52 | $19,284 | $4,177 | 21.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 51 | 51 | $136,852 | $3,957 | 2.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $69,816 | $3,717 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 50 | 57 | $14,837 | $2,866 | 19.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $39,702 | $2,455 | 6.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 17 | 19 | $120,710 | $1,833 | 1.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $9,086 | $1,645 | 18.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $63,806 | $1,566 | 2.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $25,580 | $1,025 | 4.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 15 | 15 | $2,740 | $75.10 | 2.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 54 | 55 | $219,391 | $12,444 | 5.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 61 | 62 | $48,159 | $7,190 | 14.9% |
About Edwin Mcdonald
Edwin Mcdonald is a Gastroenterology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1831346774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edwin Mcdonald has received a total of $45,780 in payments from pharmaceutical and medical device companies, with $598.57 received in 2024. These payments were reported across 55 transactions from 11 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($22,800).
As a Medicare-enrolled provider, Mcdonald has provided services to 1,665 Medicare beneficiaries, totaling 1,790 services with total Medicare billing of $193,691. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Chicago, IL
- Active Since 08/22/2008
- Last Updated 10/24/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831346774
Products in Payments
- XIFAXAN (Drug) $12,269
- CREON (Drug) $10,925
- PLENVU (Drug) $6,769
- ENTYVIO (Biological) $3,658
- RELISTOR (Drug) $2,116
- GATTEX (Drug) $1,920
- TAPERED SCREW-VENT (Device) $811.67
- ESOPHYX (Device) $136.31
- Creon (Drug) $106.42
- DUPIXENT (Biological) $84.70
- PILLCAM (Device) $29.53
- Resolution 360 ULTRA Clip (Device) $25.91
- General - Polypectomy (Device) $24.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Chicago
Stephen Hanauer, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
David Rubin
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Darren Brenner, M.d, M.D
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Steven Flamm, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Russell Cohen
Gastroenterology — Payments: $834,887
Gastroenterology $834,887
Atman Shah
Gastroenterology — Payments: $766,122
Gastroenterology $766,122